ABSTRACT
Background ■ The pharmacological treatment of personality disorders is relatively
poorly researched and evidenced. ■ Clinical trials to date have, in general, studied few patients, had short
durations of treatment (weeks), tended to use inconsistent outcome measures and had high dropout rates.
